CD34 and neoplasm: Human M-CSF promotes the development and maturation of human phagocytic monocytes and macrophages, which appears to drive the low RBC count observed in CD34+-cell-engrafted NSG-Quad and MISTRG-6 mice, and restricts the time window for tumor xenograft studies.